tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VERV Stock Latest News

Verve Therapeutics Reports Q1 2025 Progress and Financials
Company AnnouncementsVerve Therapeutics Reports Q1 2025 Progress and Financials
23d ago
VERV
Buy Rating for Verve Therapeutics: Promising Phase 1 Data and Strong Financial Position
PremiumRatings
Buy Rating for Verve Therapeutics: Promising Phase 1 Data and Strong Financial Position
23d ago
VERV
Verve Therapeutics reports Q1 EPS (35c), consensus (66c)
PremiumThe Fly
Verve Therapeutics reports Q1 EPS (35c), consensus (66c)
23d ago
VERV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PTN
ARTL
Unusually active option classes on open April 15th
PremiumThe Fly
Unusually active option classes on open April 15th
2M ago
ET
NE
Promising Prospects for Verve Therapeutics: Strong Efficacy and Safety of VERVE-102 Drive Buy Rating
PremiumRatingsPromising Prospects for Verve Therapeutics: Strong Efficacy and Safety of VERVE-102 Drive Buy Rating
2M ago
VERV
Verve Therapeutics price target raised to $24 from $18 at Guggenheim
Premium
The Fly
Verve Therapeutics price target raised to $24 from $18 at Guggenheim
2M ago
VERV
Cantor upgrades Verve Therapeutics to Overweight after positive data
Premium
The Fly
Cantor upgrades Verve Therapeutics to Overweight after positive data
2M ago
VERV
Verve Therapeutics price target raised to $39 from $32 at Canaccord
PremiumThe Fly
Verve Therapeutics price target raised to $39 from $32 at Canaccord
2M ago
VERV
Verve Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Verve Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
VERV
Verve Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe Fly
Verve Therapeutics price target raised to $25 from $15 at H.C. Wainwright
2M ago
VERV
Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study
PremiumRatings
Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study
2M ago
VERV
Verve announces initial data from Heart-2 Phase 1b trial of VERVE-102
PremiumThe FlyVerve announces initial data from Heart-2 Phase 1b trial of VERVE-102
2M ago
VERV
Verve Therapeutics receives FDA Fast Track designation for VERVE-102
Premium
The Fly
Verve Therapeutics receives FDA Fast Track designation for VERVE-102
2M ago
VERV
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
2M ago
DYN
MGX
BMO says Peter Marks resignation ‘significant negative’ for biotech
PremiumThe Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
2M ago
MGX
BEAM
Verve Therapeutics: Buy Rating Driven by FDA Clearance and Strong Market Potential
PremiumRatings
Verve Therapeutics: Buy Rating Driven by FDA Clearance and Strong Market Potential
2M ago
VERV
Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments
PremiumRatings
Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments
2M ago
VERV
Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements
PremiumRatings
Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements
2M ago
VERV
Promising Outlook for Verve Therapeutics: FDA Clearance and Strategic Partnership Drive Buy Rating
PremiumRatingsPromising Outlook for Verve Therapeutics: FDA Clearance and Strategic Partnership Drive Buy Rating
2M ago
VERV
Verve Therapeutics announces FDA clearance of IND application for VERVE-102
Premium
The Fly
Verve Therapeutics announces FDA clearance of IND application for VERVE-102
2M ago
VERV
Verve Therapeutics price target lowered to $15 from $17 at RBC Capital
Premium
The Fly
Verve Therapeutics price target lowered to $15 from $17 at RBC Capital
3M ago
VERV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >